NO20004583L - Krystallinsk form av paroxetine - Google Patents

Krystallinsk form av paroxetine

Info

Publication number: NO20004583L
Authority: NO; Norway
Prior art keywords: paroxetine; crystalline form; free; crystalline; therapy
Prior art date: 1998-03-16

Application number

NO20004583A

Other languages

English (en)

Norwegian (no)

Other versions

NO20004583D0 (no

Inventor

Andrew Simon Craig

Neal Ward

Wilson Mcilwaine

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-16

Filing date

2000-09-14

Publication date

2000-09-15

1998-03-16 Priority claimed from GBGB9805581.7A external-priority patent/GB9805581D0/en

1998-06-17 Priority claimed from GBGB9813054.5A external-priority patent/GB9813054D0/en

1998-08-06 Priority claimed from GBGB9817115.0A external-priority patent/GB9817115D0/en

2000-09-14 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2000-09-14 Publication of NO20004583D0 publication Critical patent/NO20004583D0/no

2000-09-15 Publication of NO20004583L publication Critical patent/NO20004583L/no

Links

AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title abstract 2
AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 2
229960002296 paroxetine Drugs 0.000 title abstract 2
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20004583A 1998-03-16 2000-09-14 Krystallinsk form av paroxetine NO20004583L (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GBGB9805581.7A GB9805581D0 (en)	1998-03-16	1998-03-16	Novel compounds
GBGB9813054.5A GB9813054D0 (en)	1998-06-17	1998-06-17	Novel compounds
GBGB9817115.0A GB9817115D0 (en)	1998-08-06	1998-08-06	Novel compounds
PCT/GB1999/000793 WO1999047519A1 (en)	1998-03-16	1999-03-16	Crystalline form of paroxetine

Publications (2)

Publication Number	Publication Date
NO20004583D0 NO20004583D0 (no)	2000-09-14
NO20004583L true NO20004583L (no)	2000-09-15

Family

ID=27269245

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20004583A NO20004583L (no)	1998-03-16	2000-09-14	Krystallinsk form av paroxetine

Country Status (18)

Country	Link
EP (1)	EP1064282A1 (id)
JP (1)	JP2002506865A (id)
KR (1)	KR20010041947A (id)
CN (1)	CN1300286A (id)
AP (1)	AP2000001907A0 (id)
AU (1)	AU2847199A (id)
BG (1)	BG104839A (id)
BR (1)	BR9908825A (id)
CA (1)	CA2323896A1 (id)
EA (1)	EA200000946A1 (id)
HU (1)	HUP0101215A3 (id)
ID (1)	ID27596A (id)
IL (1)	IL138390A0 (id)
NO (1)	NO20004583L (id)
PL (1)	PL342931A1 (id)
SK (1)	SK13622000A3 (id)
TR (1)	TR200002675T2 (id)
WO (1)	WO1999047519A1 (id)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH689805A8 (fr) *	1998-07-02	2000-02-29	Smithkline Beecham Plc	Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9919052D0 (en) *	1999-08-12	1999-10-13	Smithkline Beecham Plc	Novel compound composition and process
US20080033050A1 (en)	2006-08-04	2008-02-07	Richards Patricia Allison Tewe	Method of treating thermoregulatory disfunction with paroxetine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1422263A (en) *	1973-01-30	1976-01-21	Ferrosan As	4-phenyl-piperidine compounds
ES2058061T3 (es) *	1985-10-25	1994-11-01	Beecham Group Plc	Derivado de piperidina, su preparacion y su uso como medicamento.
SK283608B6 (sk) *	1995-02-06	2003-10-07	Smithkline Beecham Plc	Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie

1999
- 1999-03-16 BR BR9908825-8A patent/BR9908825A/pt not_active Application Discontinuation
- 1999-03-16 ID IDW20001813A patent/ID27596A/id unknown
- 1999-03-16 JP JP2000536714A patent/JP2002506865A/ja active Pending
- 1999-03-16 EP EP99909104A patent/EP1064282A1/en not_active Withdrawn
- 1999-03-16 AP APAP/P/2000/001907A patent/AP2000001907A0/en unknown
- 1999-03-16 CA CA002323896A patent/CA2323896A1/en not_active Abandoned
- 1999-03-16 TR TR2000/02675T patent/TR200002675T2/xx unknown
- 1999-03-16 SK SK1362-2000A patent/SK13622000A3/sk unknown
- 1999-03-16 AU AU28471/99A patent/AU2847199A/en not_active Abandoned
- 1999-03-16 HU HU0101215A patent/HUP0101215A3/hu unknown
- 1999-03-16 CN CN99806077A patent/CN1300286A/zh active Pending
- 1999-03-16 PL PL99342931A patent/PL342931A1/xx unknown
- 1999-03-16 IL IL13839099A patent/IL138390A0/xx unknown
- 1999-03-16 WO PCT/GB1999/000793 patent/WO1999047519A1/en not_active Ceased
- 1999-03-16 EA EA200000946A patent/EA200000946A1/ru unknown
- 1999-03-16 KR KR1020007010260A patent/KR20010041947A/ko not_active Withdrawn
2000
- 2000-09-14 NO NO20004583A patent/NO20004583L/no not_active Application Discontinuation
- 2000-10-11 BG BG104839A patent/BG104839A/xx unknown

Also Published As

Publication number	Publication date
EA200000946A1 (ru)	2001-02-26
NO20004583D0 (no)	2000-09-14
EP1064282A1 (en)	2001-01-03
BG104839A (en)	2001-09-28
PL342931A1 (en)	2001-07-16
WO1999047519A1 (en)	1999-09-23
BR9908825A (pt)	2000-11-21
IL138390A0 (en)	2001-10-31
HUP0101215A2 (hu)	2002-04-29
SK13622000A3 (sk)	2001-03-12
ID27596A (id)	2001-04-12
AU2847199A (en)	1999-10-11
KR20010041947A (ko)	2001-05-25
CN1300286A (zh)	2001-06-20
AP2000001907A0 (en)	2000-09-30
CA2323896A1 (en)	1999-09-23
TR200002675T2 (tr)	2000-12-21
JP2002506865A (ja)	2002-03-05
HUP0101215A3 (en)	2002-05-28

Similar Documents

Publication	Publication Date	Title
MY135732A (en)	2008-06-30	5,6-trimethylenepyrimidin - 4 - one compounds
DK0882021T3 (da)	2003-06-23	Nye phenanthridiner
BR0314603A (pt)	2005-07-26	Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos
BR9811956B1 (pt)	2010-06-01	naftiridinonas e composição farmacêutica compreendendo as mesmas.
AU8112101A (en)	2002-02-18	Non-imidazole aryloxypiperidines
NO952132L (no)	1995-05-30	Farmakologiske aktive pyridin-derivater og deres fremstilling
EP0900083A4 (en)	1999-08-25	NEW SUBSTITUTED IMIDAZOLES
PL360886A1 (en)	2004-09-20	Non-imidazole aryloxyalkylamines
DK1363608T3 (da)	2006-02-13	Formuleringer omfattende ibuprofen og diphenhydramin og deres anvendelse til behandling af sovnforstyrrelser
DE69914357D1 (de)	2004-02-26	Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
ID22042A (id)	1999-08-26	Benzonaftiridin sebagai pengobatan cabang tenggorokan
SE9900961D0 (sv)	1999-03-16	Novel compounds
DE60322102D1 (de)	2008-08-21	Transdermales buprenorphin-dosierschema zwecks schmerzstillung
NO20014529D0 (no)	2001-09-18	Tetrahydropyranderivater og deres anvendelse som terapautiske midler
SE9802208D0 (sv)	1998-06-22	Novel compounds
AU5338401A (en)	2001-10-30	Methods and compositions for modulating alpha adrenergic receptor activity
BR0213994A (pt)	2004-08-31	Derivados heterocìclicos de glicinamida e seus usos médicos
ATE213937T1 (de)	2002-03-15	Spezielle halofantrinhaltige zusammensetzungen
TR199903141T2 (xx)	2000-09-21	Terap�tik protein engelleyici sendrom i�in CD154 blokaj tedavisi.
TR200002203T2 (tr)	2000-12-21	Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi.
NO20020031L (no)	2002-03-05	Dihydrobenzodiazepiner og deres anvendelse til behandling av dyslipidemi
TR200403001T3 (tr)	2005-02-21	Lovastatin ve simvastatinin, azaltılmış dimerik katışkı seviyelerine sahip olacak şekilde arıtılması için bir işlem
NO20004583L (no)	2000-09-15	Krystallinsk form av paroxetine
SE9802209D0 (sv)	1998-06-22	Novel compounds
NZ515531A (en)	2004-03-26	Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods

Legal Events

Date	Code	Title	Description
2002-11-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application